Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd has published a notice convening its 16th Annual General Meeting in a newspaper.

Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd has published a notice for its 16th Annual General Meeting in newspapers and on its website, as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd has published a corrigendum to the notice of postal ballot for the preferential issue of warrants in two newspapers, as per SEBI regulations.

Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd has issued a corrigendum to the notice of postal ballot regarding the proposed preferential issue of share warrants, in compliance with the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The corrigendum provides additional details on the percentage of post-preferential issue capital that may be held by the allottees and the change in control, if any, in the issuer consequent to the preferential issue.

Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd has received an order from the Assistant Commissioner of Income Tax, Central Circle 2(1), Pune, under Section 154 read with Section 143(3) of the Income Tax Act, 1961, for Assessment Year 2022-23. The order rectifies the tax computation under Section 115BBE of the Income Tax Act, 1961, resulting in a differential/additional demand of Rs. 12,09,98,110/-.

Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd announces issuance of up to 16,21,000 Warrants to Mr. Rajendra Mutha and Krsnaa Diagnostics (Mumbai) Private Limited at INR 566/- each, convertible into one fully paid-up equity share of face value ₹5/- each. The issue price is determined in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018.

Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd reported a 22% year-on-year revenue growth in Q1 FY27, with like-for-like projects growing 12%. The company has been awarded a Himachal Pradesh CT project for 34 CT scans across the state, which is expected to provide revenue visibility for the next 10 years. The retail business grew 64% year-on-year, with the company expanding its retail network to over 4,000 touch points.

Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd has published a newspaper advertisement for a postal ballot notice, informing shareholders about a special resolution to issue 16,21,000 warrants convertible into equity shares on a preferential basis to the promoter and promoter group.

Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd has announced a notice of postal ballot for a preferential issue of up to 16,21,000 warrants convertible into equity shares on a preferential basis to the promoter and promoter group.

Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd has published unaudited financial results for the quarter ended June 30, 2026, in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd has announced the availability of the audio recording of its earnings call for the quarter ended June 30, 2026, as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd has released its Q1 FY2026-27 results, showing a 22% revenue growth and 12% EBITDA growth, with a moderation in margins due to upfront fixed costs. The company has also expanded its retail business, with a 64% YoY growth in revenue, 75% YoY growth in patient count, and 47% YoY growth in test volume.

Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd announced its unaudited financial results for Q1 FY2027, with revenue from operations growing 22% YoY to ₹2,355 million, and the Rajasthan pathology network transitioning from implementation to operations.

Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd announces fixation of book closure date for dividend. The company has fixed the book closure date from September 19, 2026, to September 28, 2026, for the purpose of paying a final dividend of INR 2.00 per equity share. The company has also declared unaudited financial results for the quarter ended June 30, 2026, and has recommended a final dividend for the financial year 2025-26.

Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd has announced the fixation of record date for dividend, with a final dividend of INR 2.00 per share for the financial year 2024-25. The company has also announced unaudited consolidated financial results for the quarter ended June 30, 2026, and the issuance of 16,21,000 share warrants to promoters.

Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd announced the outcome of its Board Meeting held on August 13, 2026, where it discussed and approved several items, including unaudited financial results for the quarter ended June 30, 2026, and the issuance of 16,21,000 share warrants to its promoter and promoter group. The company also declared a final dividend of INR 2.00/- (Rupees Two only) for the financial year 2024-25.

Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd has announced its unaudited consolidated financial results for the quarter ended June 30, 2026, with revenue from operations at INR 2,355.32 million, a 22.4% increase from the same period last year. The company has also declared a final dividend of INR 2.00 per share for the financial year 2024-25. Additionally, the board has approved the issuance of 16,21,000 share warrants to Mr. Rajendra Mutha and Krsna Diagnostics (Mumbai) Private Limited at a future determined price, which will be higher of the floor price as on the relevant date or INR 565.

Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd has announced its unaudited consolidated financial results for the quarter ended June 30, 2026, along with the approval of the Board of Directors for the issuance of 16,21,000 share warrants to Mr. Rajendra Mutha and Krsna Diagnostics (Mumbai) Private Limited.

Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd has scheduled a post-earnings conference call on August 14, 2026, to discuss its financial results for the quarter ended June 30, 2026.

Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/08/2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, and to consider and evaluate the proposal for raising of funds through issuance of securities.